Back to Dashboard

FIT

Consumer

Công ty Cổ phần Tập đoàn F.I.T

Y tếDược phẩmCT
3.130
VND · Last close
Valuation Verdict
Undervalued
Low
+24.8%
-120%Fair Value+120%
Current
3.130
Intrinsic Value
3.906
ModelFCF DCF

See how this valuation was built

A free account opens the full working: every step of the calculation, the statements it reads and the scores derived from them.

Create a free account

Free, and it takes one click with Google.

See how the value moves with WACC and growth

Investor opens the parts that take the most work to produce: the year-by-year track record, the forensic analysis and the ownership network.

See Investor
Research Note

FIT: consumer/pharma distributor with low-margin profile and concentrated ownership; valuation implies limited buffer

Intrinsic value VND 3,881 vs market VND 3,110 — implied upside 24.8% (confidence: low).

Business Overview

Công ty Cổ phần Tập đoàn F.I.T (FIT) operates in the consumer / pharmaceutical distribution segment listed on HOSE. The company reported revenue of VND 2,073.2 bn in 2025, up from VND 1,953.7 bn in 2024 and VND 1,745.8 bn in 2023, reflecting modest top-line growth. FIT's business mix sits in the 'Dược phẩm' ICB3 category, with distribution/wholesale and related consumer healthcare exposure. The group has total assets of VND 8,026.7 bn at end-2025 and a net debt position reported in the valuation model of VND 1,412,076,194,128 (model input).

Investment Thesis

FIT's valuation implies limited upside (24.8%) to our intrinsic value of VND 3,881 per share while the model confidence is explicitly flagged as low. Operationally the company generates thin profitability: ROE is 1.0% and ROA 0.5% (latest ratios), with an EBIT margin of 1.2% and net profit margin of 2.8%, which constrains downside protection. Revenue growth has been steady but modest: 6.3% YoY most recently. On the plus side, the company carries a low market multiple relative to fundamentals — P/B of 0.27 and P/S of 0.51 — which provides some valuation cushion if operational improvement materializes.

Key negatives: earnings quality is middling (70.0/100) and the largest shareholder, Công ty Cổ phần Đầu tư JJK Holdings, holds 30.4%, creating meaningful ownership concentration and potential related-party or strategic-direction risk. The model's WACC is 10.0% with a low terminal growth assumption of 4.0%, and the blended intrinsic value combines a DCF-dominated approach (70% weight) with a PE approach (30% weight), producing the current VND 3,881 figure; however the model flags an 'extreme_upside' in raw outputs and the team calibrated confidence down to low.

Given the 24.8% implied upside but low model confidence and execution / margin risks, the implied return is not large enough to compensate for operational and governance uncertainties.

Valuation Commentary

Blended intrinsic valuation: 70% DCF of forecasted free cash flows and 30% PE-based terminal valuation.

  • Base free cash flow input: VND 1,210,740,564,093 (model base_fcf).
  • WACC assumed at 10.0%, terminal growth 4.0%, projection horizon 10 years — TV contributes 57.07% of value (tv_pct 0.5707).
  • PE leg uses a 'fair_pe' of 13.37 with a PE cap at 25; blended weights are DCF 0.7 / PE 0.3.
  • Net debt in the model: VND 1,412,076,194,128; growth driver anchored to roic 0.37% and reinvestment rate 66.67%.

The blended model yields an intrinsic value of VND 3,881 (implied upside 24.8%) but the calibration flagged low confidence due to raw model outputs and a recalibrated confidence source. Because confidence is low and the DCF dominates value (70%), small changes to WACC, terminal growth or free cash flow trajectory materially change the result — treat the target as an indicative reference rather than a high-conviction fair price.

Bull vs Bear

Bull Case
  • Valuation discounts current fundamentals: P/B 0.27 and P/S 0.51 imply market price does not fully reflect asset base (BVPS VND 11,393).
  • Revenue growth has been steady: VND 2,073.2 bn in 2025 vs VND 1,953.7 bn in 2024 (6.3% YoY), supporting gradual margin expansion if scale benefits occur.
  • Low net leverage on reported ratios (Debt/Equity 0.33) gives room to support operations and potential M&A or distribution scale-ups.
Bear Case
  • Profitability is weak: ROE 1.0%, ROA 0.5% and EBIT margin 1.2%, limiting cash generation and upside for equity holders.
  • Model confidence is low and the valuation is sensitive to WACC (10.0%) and terminal growth (4.0%); TV already accounts for 57.07% of value, concentrating model risk in long-term assumptions.
  • Top shareholder owns 30.4%, concentrating control and raising governance and related-party risk despite small public float (foreign_room 0.0%).
  • Historical profitability is volatile: net profit swung from a loss of VND 114.9 bn in 2023 to VND 119.3 bn in 2024 and back to VND 40.0 bn in 2025, indicating execution risk.

Sector Context

Pharmaceuticals and consumer distribution in Vietnam operate under VAS accounting and sector-specific dynamics: inventory and trade receivables are material and can hide working-capital swings under VAS practices. Banks and distributors face capital allocation constraints from SBV credit-growth guidance and state ownership rules when dealing with SOE counterparties. FIT's peer universe (351 peers) has a median implied upside of 12.0%, and the top sector comparators show high dispersion: peers' upside ranges from strongly positive (>36%) to deeply negative (<-43%). FIT's foreign ownership room is 0.0%, which limits FOL-driven re-rating opportunities and dampens potential offshore demand.

Risk Factors

  • Low profitability: ROE 1.0% and EBIT margin 1.2% leave little buffer for shocks to revenue or margins.
  • Ownership concentration: largest shareholder holds 30.4%, which can influence capital allocation and related-party transactions.
  • Model risk: intrinsic value driven by DCF (70% weight) with low-confidence calibration and a high TV share (57.07%), making the target sensitive to small assumption changes.
  • Volatile earnings history: net profit swung materially across 2023–2025 (VND -114.9 bn -> VND 119.3 bn -> VND 40.0 bn).
  • Zero foreign room (foreign_room 0.0) restricts demand-side flows from foreign institutional investors.
  • Sector-specific working-capital risk under VAS: inventory/receivables can move suddenly and affect cash flow more than under IFRS comparables.

Catalysts

  • Improvement in operating margins or ROE that raises confidence in cash-flow sustainability (ROE currently 1.0%).
  • Positive quarterly earnings surprise or a return to consistent net profit growth above 2024 levels (net profit VND 119.3 bn in 2024).
  • Corporate actions that reduce ownership concentration or unlock foreign_room could re-rate the stock.

Forensic Assessment

There is no M-Score reported and no explicit forensic red flags in the input. Earnings quality is moderate at 70.0/100, suggesting reasonable but not pristine accounting transparency. Given the ownership concentration (30.4% by the largest institutional holder) and volatile net profits between 2023–2025, monitor related-party transactions and receivables/inventory disclosures closely for potential earnings-management signals.

Track Record

The model's historical track record spans 12 years with a hit rate of 45.5% and an average realized upside of -28.6%. The hit rate is below 50%, indicating limited historical predictive reliability; use current model outputs cautiously and emphasise scenario analysis rather than blind reliance on point estimates.

Written by a language model on 2026-08-10 from this page’s own model outputs and financial statements, and may quote figures from that date. Descriptive analysis, not investment advice — no buy, sell or hold recommendation is given or implied.

See the statements behind the number

A free account opens the full working: every step of the calculation, the statements it reads and the scores derived from them.

Create a free account

Free, and it takes one click with Google.

See the 2015-present track record

Investor opens the parts that take the most work to produce: the year-by-year track record, the forensic analysis and the ownership network.

See Investor

See the earnings-quality breakdown

A free account opens the full working: every step of the calculation, the statements it reads and the scores derived from them.

Create a free account

Free, and it takes one click with Google.

Financial Forensics

Beneish M-Score · 2025

Low Risk
M -3.34 · 8th pctile vs peers
YoY -1.06
Conservative vs VN peersAggressive
Compare across the whole market

Ranked vs Vietnamese peers. The −1.78 Beneish cutoff is US-calibrated; ~28% of VN stocks exceed it.

DSRI
0.604
GMI
1.078
AQI
1.438
SGI
1.061
DEPI
1.758
SGAI
0.963
TATA
-0.179
LVGI
1.062

See the Piotroski, Altman and DuPont detail

A free account opens the full working: every step of the calculation, the statements it reads and the scores derived from them.

Create a free account

Free, and it takes one click with Google.

Key Ratios

Fiscal year 2025
26.61P/E
P/B0.27
P/S0.51
ROE1.0%
ROA0.5%
EPS117.62
BVPS11393.06
Gross Margin18.7%
Net Margin2.8%
D/E0.33
Current Ratio2.82
Rev Growth6.3%
Profit Growth-66.2%
EV/EBITDA13.56
Div Yield0.0%

Company Overview

Issued Shares
339.9M
Charter Capital
3399.3B VND
Sector (ICB L2)
Y tế
Industry (ICB L3)
Dược phẩm
Sub-industry
Dược phẩm
Company Type
CT

See who owns this company, and what else they own

Investor opens the parts that take the most work to produce: the year-by-year track record, the forensic analysis and the ownership network.

See Investor
Computed 28/08/2026
Methodology & Disclosure

vnvalue is a methodology engine — not an advisor. Every number is the deterministic output of a published formula applied to public financial data. Nothing on this page constitutes investment, financial, legal, or tax advice, nor a recommendation to buy, sell, or hold any security.

All data, models, and outputs are provided AS IS without warranty of any kind. You are solely responsible for your investment decisions. Past performance and historical valuations are not indicative of future results.

By using vnvalue you accept the Terms of Service and Privacy Policy. Full disclaimer →